SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova informs about AGM notice and annual report

09 Aug 2024 Evaluate

Pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that it enclosed the following documents: 1. Notice of the 46th AGM (including e-voting instructions) (AGM Notice) 2. Annual Report for the Financial Year 2023-24 (Annual Report). The important information with respect to the 46th AGM and e-voting are as follows: • The 46th AGM of the Company is scheduled to be held on Friday, August 30, 2024, at 11:00 am (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). • The AGM notice and Annual Report for the Financial Year 2023-24 have been sent to all the members of the Company whose email addresses are registered with the Company/ Depository Participant(s) as on Friday, August 2, 2024. • The Company has provided the facility to vote by electronic means (remote e-voting as well as e-voting at the AGM) to the members who are holding shares on the Cut-off date i.e. Friday, August 23, 2024. • The remote e-voting will commence at 9:00 am (IST) on Tuesday, August 27, 2024 and end at 5:00 pm (IST) on Thursday, August 29, 2024. • Other important information including detailed procedure for remote e-voting before and during the AGM has been provided in the notes forming part of the AGM Notice. The above documents are also available on the Company’s website www.jubilantpharmova.com (link attached).

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

911.60 6.55 (0.72%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×